The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> October 20, 2024

Interview with the President and Executive Chairman: NanoViricides, Inc. (NYSEAMERICAN:NNVC)

Diwan, Anil R.
Dr. Anil Diwan, Ph.D., is President and Executive Chairman of NanoViricides, Inc. He co-invented a bio-mimetic drug delivery platform, nanoviricides polymeric micelles, enabling site-specific targeting, multi-point attack, and encapsulation. Orally available, host-mimetic, direct-acting, nanoviricide drug NV-387 has successfully completed Phase I in healthy subjects and is being developed into Phase II. NV-387 has shown strong pre-clinical efficacy in RSV, influenza, COVID as well as Orthopoxvirus in lethal virus challenge animal models, attesting to its broad spectrum, reminiscent of antibiotics. Nanoviricides define a new paradigm “Re-Infection Inhibition,” going beyond antibodies and small chemicals. The platform further enables cures of viral infections by encapsulating orthogonal APIs ex: Remdesivir, Ribavirin, Cidofovir, etc. Dr. Diwan was instrumental in designing and establishing the NanoViricides campus in Shelton that comprises R&D to Clinical Trial Drug Product Manufacturing facility of its nanomedicines. Dr. Diwan holds a Ph.D., (Bio)Chemical Engineering, Rice University and a BTech, Chemical Engineering, Indian Institute of Technology, Bombay (IITB). Profile
Word count: 3,571

TWST: It’s been a while since you last spoke with The Wall Street Transcript. That was back in 2018, and a lot of significant progress has been achieved by your company

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc
CEO INTERVIEWS
Interview with the President and CEO: Premier Inc. (NASDAQ:PINC)
Interview with the CEO: Neuren Pharmaceuticals Ltd. (OTCMKTS:NURPF)
Interview with the President and Executive Chairman: NanoViricides, Inc. (NYSEAMERICAN:NNVC)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
New Drug Trials Spur Continued Interest in Anti-Obesity Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy